Levomart Tablet is a combination medication containing Levocetirizine 5mg and Montelukast 10mg, indicated for the management of allergic conditions such as allergic rhinitis and chronic urticaria. Levocetirizine, a second-generation antihistamine, selectively inhibits peripheral H1 receptors, thereby reducing symptoms like sneezing, itching, rhinorrhea, and nasal congestion associated with allergic reactions. Montelukast, a leukotriene receptor antagonist, blocks the effects of leukotrienes, which are inflammatory mediators involved in bronchoconstriction, mucus production, and airway edema. The synergistic action of these two agents provides comprehensive relief from allergy symptoms and helps in controlling airway inflammation, making Levomart effective in both upper and lower respiratory allergic conditions. This combination is particularly beneficial for patients who require both antihistaminic and anti-inflammatory effects to manage their symptoms effectively. Levomart is generally well tolerated; however, patients should be advised to follow prescribed dosages and consult healthcare providers if adverse effects such as headache, fatigue, or gastrointestinal disturbances occur. It is contraindicated in individuals with known hypersensitivity to any component of the formulation. Levomart Tablet should be used under medical supervision, especially in patients with hepatic or renal impairment.